Literature DB >> 31043530

Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.

Lisa Miorin1,2, Maudry Laurent-Rolle3, Giuseppe Pisanelli1,2,4, Pierre Hendrick Co5, Randy A Albrecht1,2, Adolfo García-Sastre6,2,7, Juliet Morrison8.   

Abstract

The recent yellow fever virus (YFV) epidemic in Brazil in 2017 and Zika virus (ZIKV) epidemic in 2015 serve to remind us of the importance of flaviviruses as emerging human pathogens. With the current global flavivirus threat, there is an urgent need for antivirals and vaccines to curb the spread of these viruses. However, the lack of suitable animal models limits the research questions that can be answered. A common trait of all flaviviruses studied thus far is their ability to antagonize interferon (IFN) signaling so as to enhance viral replication and dissemination. Previously, we reported that YFV NS5 requires the presence of type I IFN (IFN-α/β) for its engagement with human signal transducer and activator of transcription 2 (hSTAT2). In this manuscript, we report that like the NS5 proteins of ZIKV and dengue virus (DENV), YFV NS5 protein is able to bind hSTAT2 but not murine STAT2 (mSTAT2). Contrary to what has been demonstrated with ZIKV NS5 and DENV NS5, replacing mSTAT2 with hSTAT2 cannot rescue the YFV NS5-STAT2 interaction, as YFV NS5 is also unable to interact with hSTAT2 in murine cells. We show that the IFN-α/β-dependent ubiquitination of YFV NS5 that is required for STAT2 binding in human cells is absent in murine cells. In addition, we demonstrate that mSTAT2 restricts YFV replication in vivo These data serve as further impetus for the development of an immunocompetent mouse model that can serve as a disease model for multiple flaviviruses.IMPORTANCE Flaviviruses such as yellow fever virus (YFV), Zika virus (ZIKV), and dengue virus (DENV) are important human pathogens. A common flavivirus trait is the antagonism of interferon (IFN) signaling to enhance viral replication and spread. We report that like ZIKV NS5 and DENV NS5, YFV NS5 binds human STAT2 (hSTAT2) but not mouse STAT2 (mSTAT2), a type I IFN (IFN-α/β) pathway component. Additionally, we show that contrary to what has been demonstrated with ZIKV NS5 and DENV NS5, YFV NS5 is unable to interact with hSTAT2 in murine cells. We demonstrate that mSTAT2 restricts YFV replication in mice and that this correlates with a lack of IFN-α/β-induced YFV NS5 ubiquitination in murine cells. The lack of suitable animal models limits flavivirus pathogenesis, vaccine, and drug research. These data serve as further impetus for the development of an immunocompetent mouse model that can serve as a disease model for multiple flaviviruses.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  NS5; STAT2; flavivirus; host tropism; interferon; interferon antagonism; yellow fever virus

Mesh:

Substances:

Year:  2019        PMID: 31043530      PMCID: PMC6600188          DOI: 10.1128/JVI.00151-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation.

Authors:  Jason J Rodriguez; Jean-Patrick Parisien; Curt M Horvath
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Mouse STAT2 restricts early dengue virus replication.

Authors:  Joseph Ashour; Juliet Morrison; Maudry Laurent-Rolle; Alan Belicha-Villanueva; Courtney Ray Plumlee; Dabeiba Bernal-Rubio; Katherine L Williams; Eva Harris; Ana Fernandez-Sesma; Christian Schindler; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

3.  A small animal peripheral challenge model of yellow fever using interferon-receptor deficient mice and the 17D-204 vaccine strain.

Authors:  Brett A Thibodeaux; Nina C Garbino; Nathan M Liss; Joseph Piper; Carol D Blair; John T Roehrig
Journal:  Vaccine       Date:  2012-03-13       Impact factor: 3.641

4.  Transgenic mice expressing a human poliovirus receptor: a new model for poliomyelitis.

Authors:  R B Ren; F Costantini; E J Gorgacz; J J Lee; V R Racaniello
Journal:  Cell       Date:  1990-10-19       Impact factor: 41.582

5.  Murine Stat2 is uncharacteristically divergent.

Authors:  C Park; M J Lecomte; C Schindler
Journal:  Nucleic Acids Res       Date:  1999-11-01       Impact factor: 16.971

6.  STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor.

Authors:  Stuart T Perry; Michael D Buck; Steven M Lada; Christian Schindler; Sujan Shresta
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

7.  NS5 of dengue virus mediates STAT2 binding and degradation.

Authors:  Joseph Ashour; Maudry Laurent-Rolle; Pei-Yong Shi; Adolfo García-Sastre
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

8.  A genetically humanized mouse model for hepatitis C virus infection.

Authors:  Marcus Dorner; Joshua A Horwitz; Justin B Robbins; Walter T Barry; Qian Feng; Kathy Mu; Christopher T Jones; John W Schoggins; Maria Teresa Catanese; Dennis R Burton; Mansun Law; Charles M Rice; Alexander Ploss
Journal:  Nature       Date:  2011-06-08       Impact factor: 49.962

9.  A mouse model for studying viscerotropic disease caused by yellow fever virus infection.

Authors:  Kathryn C Meier; Christina L Gardner; Mikhail V Khoretonenko; William B Klimstra; Kate D Ryman
Journal:  PLoS Pathog       Date:  2009-10-09       Impact factor: 6.823

10.  Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling.

Authors:  Juliet Morrison; Maudry Laurent-Rolle; Ana M Maestre; Ricardo Rajsbaum; Giuseppe Pisanelli; Viviana Simon; Lubbertus C F Mulder; Ana Fernandez-Sesma; Adolfo García-Sastre
Journal:  PLoS Pathog       Date:  2013-03-28       Impact factor: 6.823

View more
  12 in total

1.  Immune Evasion Strategies Used by Zika Virus to Infect the Fetal Eye and Brain.

Authors:  Branden R Nelson; Justin A Roby; William B Dobyns; Lakshmi Rajagopal; Michael Gale; Kristina M Adams Waldorf
Journal:  Viral Immunol       Date:  2019-11-05       Impact factor: 2.257

Review 2.  Type I and Type II Interferon Antagonism Strategies Used by Paramyxoviridae: Previous and New Discoveries, in Comparison.

Authors:  Giuseppe Pisanelli; Ugo Pagnini; Giuseppe Iovane; Adolfo García-Sastre
Journal:  Viruses       Date:  2022-05-21       Impact factor: 5.818

Review 3.  Contributions of Ubiquitin and Ubiquitination to Flaviviral Antagonism of Type I IFN.

Authors:  Erika Hay-McCullough; Juliet Morrison
Journal:  Viruses       Date:  2021-04-27       Impact factor: 5.048

Review 4.  Human Type I Interferon Antiviral Effects in Respiratory and Reemerging Viral Infections.

Authors:  Patricio L Acosta; Alana B Byrne; Diego R Hijano; Laura B Talarico
Journal:  J Immunol Res       Date:  2020-05-08       Impact factor: 4.818

Review 5.  Importance of Zika Virus NS5 Protein for Viral Replication.

Authors:  Hesham Elshahawi; Sharifah Syed Hassan; Vinod Balasubramaniam
Journal:  Pathogens       Date:  2019-09-30

6.  STAT2 Limits Host Species Specificity of Human Metapneumovirus.

Authors:  Meredith C Rogers; Margot Miranda-Katz; Yu Zhang; Tim D Oury; Melissa B Uccellini; Adolfo García-Sastre; John V Williams
Journal:  Viruses       Date:  2020-07-04       Impact factor: 5.048

Review 7.  The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses.

Authors:  Karl M Valerdi; Adam Hage; Sarah van Tol; Ricardo Rajsbaum; Maria I Giraldo
Journal:  Viruses       Date:  2021-02-26       Impact factor: 5.048

Review 8.  Mechanisms of Viral Degradation of Cellular Signal Transducer and Activator of Transcription 2.

Authors:  Sailen Barik
Journal:  Int J Mol Sci       Date:  2022-01-01       Impact factor: 5.923

Review 9.  Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus.

Authors:  Robin D V Kleinert; Eduardo Montoya-Diaz; Tanvi Khera; Kathrin Welsch; Birthe Tegtmeyer; Sebastian Hoehl; Sandra Ciesek; Richard J P Brown
Journal:  Viruses       Date:  2019-10-17       Impact factor: 5.048

10.  Consumptive coagulopathy of severe yellow fever occurs independently of hepatocellular tropism and massive hepatic injury.

Authors:  Adam L Bailey; Liang-I Kang; Luiz Gonzaga Francisco de Assis Barros D'Elia Zanella; Cássia G T Silveira; Yeh-Li Ho; Lander Foquet; Greg Bial; Broc T McCune; Amaro Nunes Duarte-Neto; Archana Thomas; Hans-Peter Raué; Kathleen Byrnes; Esper G Kallas; Mark K Slifka; Michael S Diamond
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-02       Impact factor: 12.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.